Pearl River Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,094
Closed -$3.27M 553
2023
Q3
$3.27M Buy
+6,094
New +$3.14M 0.51% 43
2022
Q4
Sell
-1,430
Closed -$462K 547
2022
Q3
$462K Buy
+1,430
New +$453K 0.09% 297
2021
Q4
Sell
-4,905
Closed -$1.13M 506
2021
Q3
$1.13M Buy
+4,905
New +$1.21M 0.31% 106
2021
Q2
Sell
-19,909
Closed -$3.72M 505
2021
Q1
$3.72M Buy
+19,909
New +$3.89M 1.19% 9
2020
Q4
Sell
-13,072
Closed -$1.94M 452
2020
Q3
$1.94M Buy
+13,072
New +$2.02M 0.81% 16
2020
Q2
Sell
-4,688
Closed -$650K 460
2020
Q1
$650K Buy
4,688
+1,904
+68% +$262K 1.25% 10
2019
Q4
$366K Buy
2,784
+2,584
+1,292% +$300K 0.14% 273
2019
Q3
$22K Sell
200
-609
-75% -$67.8K 0.06% 262
2019
Q2
$90K Buy
+809
New +$95.3K 0.57% 85

Other funds holding LLY

Pearl River Capital's LLY Position: Q4 2023 in Review

Pearl River Capital sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 6,094 shares — an estimated $3.27M sold.

Pearl River Capital first reported a position in LLY in Q2 2019 and held it in 9 quarters. The position peaked at $3.72M in Q1 2021. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Pearl River Capital reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Pearl River Capital sold 6,094 Eli Lilly shares in Q4 2023, an estimated $3.27M.
  • Pearl River Capital first reported a position in Eli Lilly in Q2 2019 and held it in 9 quarters.
  • Pearl River Capital's Eli Lilly position peaked at $3.72M in Q1 2021.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Pearl River Capital's 13F filing for Q4 2023, filed 13 Feb 2024.